Imidazole compounds and their therapeutic applications

US5559113A · kind A · utility

Assignees

• Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
• BIOPROJET · FR

Inventors

• Jean-Charles Schwartz · Paris, FR
• Jean-Michel Arrang · Gif-sur-Yvette, FR
• Monique Garbarg · Paris, FR
• Jeanne-Marie Lecomte · Paris, FR
• Charon R. Ganellin · Welwyn Garden City, GB
• Abdellatif Fkyerat · La Bassée, FR
• Wasyl Tertiuk · Welwyn Garden City, GB
• Walter Schunack · Berlin, DE
• Ralph Lipp · Berlin, DE
• Holger Stark · Bad Homburg vor der Höhe, DE
• Katja Purand · Berlin, DE

Key dates

• Filing date: Jan 28, 1994
• Grant date: Sep 24, 1996
• Expiry date: Jan 28, 2014

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A compound selected from the group consisting of a compound of the formula ##STR1## wherein the substituents are defined as in the specification having antagonist properties to histamine H.sub.3 -receptors.